Shifa Remedies

Delhi, India Founded: 2021 • Age: 5 yrs
Manufactures haemodialysis powder concentrates and supplies to dialysis service providers.

About Shifa Remedies

Shifa Remedies is a Healthcare company based in Delhi (India) founded in 2021. It manufactures haemodialysis powder concentrates and supplies to dialysis service providers. It operates on a B2B model. Its Indian entity Shifa Remedies Private Limited reported revenue of ₹37.06 Cr. Shifa Remedies offers products and services including DRY CITRASATE SR–BICARB-CL, DRY BICARBONATE CONCENTRATE, FISTULA NEEDLE, BLOOD TUBING, and DIALYZER. Its focus areas include Medical Devices, Dialysis and Haemodialysis Concentrates.

Company details

Shifa Remedies, established in 2005, focuses on producing and marketing haemodialysis powder concentrates as the exclusive licensee for DRY CITRASATE in India and neighboring countries. They supply products to major dialysis service providers through a pan-India distribution network. Based in New Delhi, the company emphasizes quality and innovation in medical devices for patient care, serving healthcare facilities across the region.

  • Headquarters Delhi, India
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Website shifaremedies.in
  • Legal Name Shifa Remedies Private Limited
  • Date of Incorporation 20 Apr, 2005
  • Jurisdiction New Delhi, Delhi, India
Operational Areas
Key Metrics
  • Annual Revenue
    ₹37.06 Cr

    FY 2025 · +6% YoY

  • Net Profit
    ₹73.3 Lakh

    FY 2025 · 2% margin

  • EBITDA
    ₹1.75 Cr

    FY 2025 · 5% margin

Products & Services of Shifa Remedies

Shifa Remedies offers a comprehensive portfolio of products and services, including DRY CITRASATE SR–BICARB-CL, DRY BICARBONATE CONCENTRATE, FISTULA NEEDLE, BLOOD TUBING, and DIALYZER.

DRY CITRASATE SR–BICARB-CL
Dialysis Concentrate

Haemodialysis concentrate for improved dialysis treatment efficacy.

DRY BICARBONATE CONCENTRATE
Dialysis Consumable

Bicarbonate-based solution for haemodialysis processes.

FISTULA NEEDLE
Dialysis Equipment

Needle for vascular access in dialysis procedures.

BLOOD TUBING
Dialysis Consumable

Tubing system for blood circulation during dialysis.

DIALYZER
Dialysis Device

Filter device used in haemodialysis treatments.

CONCENTRATE MIXER
Dialysis Equipment

Machine for mixing dialysis concentrates accurately.

Board of directors of Shifa Remedies Private Limited (Shifa Remedies)

Shifa Remedies Private Limited is the primary company behind Shifa Remedies. The board of Shifa Remedies Private Limited currently have 4 directors; the longest-serving is Arif Sayeed Khan, appointed in 2005. 1 earlier director has ceased.

DirectorDesignationAppointedTenureEntity
Arif Sayeed Khan
DIN 01390254
Director20 Apr 200521 yrs 6 moShifa Remedies Private Limited
Mohammad Tariq
DIN 01390336
Director20 Apr 200521 yrs 6 moShifa Remedies Private Limited
Asif S Khan
DIN 01546934
Director11 Feb 200818 yrs 9 moShifa Remedies Private Limited
Akbar Khan
DIN 10479752
Additional Director22 Dec 202510 moShifa Remedies Private Limited

Financials of Shifa Remedies

Figures of Shifa Remedies Private Limited, the primary company behind Shifa Remedies, for FY 2025. Revenue was ₹37.06 Cr (+6% year on year). Net profit was ₹73.3 Lakh (2% margin). EBITDA was ₹1.75 Cr (5% margin). Revenue has grown at a compounded annual rate of +27% over three years and +13% over five years.

  • ₹37.06 CrRevenue · FY 2025 · +6% YoY
  • ₹73.3 LakhNet profit · 2% margin
  • ₹1.75 CrEBITDA · 5% margin
  • ₹1 LakhPaid-up capital
  • +27%Revenue CAGR, 3 years
  • +13%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Shifa Remedies Private Limited are on its company page.

Premium access

Detailed financial statements for Shifa Remedies

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Shifa Remedies

Shifa Remedies was founded in 2021.

Shifa Remedies is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.

The primary company behind Shifa Remedies, Shifa Remedies Private Limited, reported revenue of ₹37.06 Cr for FY 2025, up 6% year on year.

Shifa Remedies, established in 2005, focuses on producing and marketing haemodialysis powder concentrates as the exclusive licensee for DRY CITRASATE in India and neighboring countries. They supply products to major dialysis service providers through a pan-India distribution network. Based in New Delhi, the company emphasizes quality and innovation in medical devices for patient care, serving healthcare facilities across the region.

Shifa Remedies offers DRY CITRASATE SR–BICARB-CL, DRY BICARBONATE CONCENTRATE, FISTULA NEEDLE, BLOOD TUBING, and 2 more products and services.

Shifa Remedies operates through Shifa Remedies Private Limited.

The legal entities of Shifa Remedies currently have 4 directors, including Arif Sayeed Khan, Mohammad Tariq, Asif S Khan and others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available